Organogenesis Holdings (ORGO) EPS (Basic) Growth (3y) (2019 - 2026)
Organogenesis Holdings (ORGO) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 243.84 Mn | 196.99 Mn | 20.08 Mn | -176.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -176.19% |
| Mar 31, 2026 | -168.71% |
| Dec 31, 2025 | 77.46% |
| Sep 30, 2025 | 311.54% |
| Jun 30, 2025 | -50.75% |
| Mar 31, 2025 | -188.91% |
| Dec 31, 2024 | -32.98% |
| Sep 30, 2024 | -1.67% |
| Jun 30, 2024 | -40.89% |
| Mar 31, 2024 | -30.15% |
| Dec 31, 2023 | -59.45% |
| Sep 30, 2023 | -50.54% |
| Jun 30, 2023 | 41.29% |
| Mar 31, 2023 | 47.46% |
| Dec 31, 2022 | 59.72% |
| Sep 30, 2022 | 26.27% |
| Jun 30, 2022 | 38.10% |
| Mar 31, 2022 | 65.52% |
| Dec 31, 2021 | 45.97% |
| Sep 30, 2021 | 27.52% |